These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16532635)

  • 1. [Protective effect of the aerosol immunization of mice with the polycomponent vaccine Immunovac VP-4 after the challenge of the animals with Klebsiella pneumoniae virulent strain].
    Solov'ev KG; Kurbatova EA; Egorova NB; Uspenskaia SN; Tret'iakova AV; Varfolomeev AN; Gruber IM; Efremova VN; Akhmatova NK; Diadizhshev NR; Akhmatova IB; Diadishchev NR; Semenova IB; Cherkasova LS; Semenov BF; Borovik RV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):20-5. PubMed ID: 16532635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
    Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunostimulating activity of polycomponent vaccine "Immunovac-VP-4" and grippol after their combined administration].
    Kurbatova EA; Semenov BF; Egorova NB; Efremova VN; Gruber IM; Semenova IB; Kushchenko OM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):34-9. PubMed ID: 15346947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of methods of application of bacterial ligands on activation of lymphoid organs' effectors in mice].
    Akhmatova NK; Chertov IV; Akhmatov EA; Kurbatova EA; Egorova NB; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):56-61. PubMed ID: 20737684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity].
    Kurbatova EA; Lazareva ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):75-9. PubMed ID: 3061265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
    Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of various routes of vaccination and testing. An instance of a killed bacterial vaccine].
    Binder P; du Colombier P; Bureau Fontanges R
    Poumon Coeur; 1982; 38(5):317-23. PubMed ID: 6760155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective activity of a cell-free Klebsiella vaccine in relation to different Klebsiella pneumoniae serovars].
    Kurbatova EA; Egorova NB; Kiseleva BS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):80-3. PubMed ID: 6385585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
    Lavender H; Jagnow JJ; Clegg S
    Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of therapeutic polycomponent vaccine "Immunovac VP-4" for the treatment of chronic bacterial prostatitis].
    Bondarenko VM; Vershinin AE; Kucherskiĭ VM; Mitkov VG; Klimova NE; Kurbatova EA; Egorova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):39-43. PubMed ID: 15346948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An evaluation of the protective activity of a multicomponent vaccine made from opportunistic microorganisms in the oral method of immunization in a model of local staphylococcal infection].
    Efremov VN; Poliachenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):73-6. PubMed ID: 8067121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a trivalent Klebsiella pneumoniae vaccine confers protection in a murine model of pneumonia.
    Chen Z; Gou Q; Yuan Y; Zhang X; Zhao Z; Liao J; Zeng X; Jing H; Jiang S; Zhang W; Zeng H; Huang W; Zou Q; Zhang J
    Vaccine; 2024 Oct; 42(23):126217. PubMed ID: 39163713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Elimination of Klebsiella pneumoniae and humoral immunity in immunization with the IS-4 immunostimulating mixture].
    Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):71-5. PubMed ID: 3518307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the immunogenicity of a monopreparation of Klebsiella pneumoniae antigen complex and its association with Staphylococcus, Proteus and Escherichia coli antigens].
    Egorova NB; Mansurova NL; Kurbatova EA; Efremova VN; Kreĭnin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):35-8. PubMed ID: 6367319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The intensity and dynamics of the development of immunity in the administration of experimental corpuscular ozena vaccines].
    Molochko VA; Krasil'nikov AP; Krylov IA; Lastochkina TM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):49-52. PubMed ID: 3414235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprotective efficacy of 3 Klebsiella pneumoniae type I fimbriae proteins in a murine model.
    Tong X; Cao Z; Cheng S; Zhang B; Li X; Kastelic JP; Xu C; Han B; Gao J
    Vet Microbiol; 2024 Oct; 297():110197. PubMed ID: 39126781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent efficacy of vaccination against K. pneumoniae in high and low antibody responder lines of mice.
    Mouton D; Parant M; Mevel JC; Parant F
    Immunol Lett; 1987 Apr; 14(4):335-9. PubMed ID: 3294582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever].
    Poddubikova AM; Kostinov MP
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.